tirzepatide shortage Resolved: What It Means for Your Weight Loss Journey GLP-1 Saga Continues: FDA Ends

Tirzepatide is the active ingredient in Zepbound and Mounjaro

HSA and FSA accounts are accepted, making treatment accessible and budget-friendly for individuals managing insulin resistance

For those exploring the full landscape of what peptides and GLP-1 compounds can do for body composition, the peptides for fat loss resource and the peptides for muscle growth guide provide broader context on how different compounds interact with body recomposition goals

Pietrobon, D., & Moskowitz, M

Some people seek out compounded GLP-1s because they do not qualify for a prescription but want to lose weight

The SURPASS trials (studying tirzepatide for diabetes) showed approximately 5 to 13 percent weight loss over 40 to 52 weeks, compared to 16 to 22.5 percent in the SURMOUNT obesity trials